Publication:
Dual action-based approaches to antibacterial agents

Simple item page
dc.contributor.authorBremner J.B.
dc.contributor.authorAmbrus J.I.
dc.contributor.authorSamosorn S.
dc.date.accessioned2021-04-05T04:32:10Z
dc.date.available2021-04-05T04:32:10Z
dc.date.issued2007
dc.date.issuedBE2550
dc.description.abstractThis review collates and analyses recent work done on dual action approaches to tackling the mounting health problem of resistance by human pathogenic bacteria to antibacterial agents. In particular the areas reviewed include the use of two drugs in combination, dual action prodrugs, and dual action drugs (or hybrid drugs). © 2007 Bentham Science Publishers Ltd.
dc.format.mimetypeapplication/pdf
dc.identifier.citationCurrent Medicinal Chemistry. Vol 14, No.13 (2007), p.1459-1477
dc.identifier.doi10.2174/092986707780831168
dc.identifier.issn9298673
dc.identifier.other2-s2.0-34250160226
dc.identifier.urihttps://hdl.handle.net/20.500.14740/4556
dc.rights.holderScopus
dc.subject.otherAminoglycoside antibiotic agent
dc.subject.otherAmoxicillin
dc.subject.otherAmoxicillin plus clavulanic acid
dc.subject.otherAntiinfective agent
dc.subject.otherBeta lactam
dc.subject.otherCefamandole
dc.subject.otherCefotaxime
dc.subject.otherCephalosporin
dc.subject.otherChloramphenicol
dc.subject.otherCiprofloxacin
dc.subject.otherClarithromycin
dc.subject.otherCotrimoxazole
dc.subject.otherCytotoxic agent
dc.subject.otherDalfopristin plus quinupristin
dc.subject.otherEnrofloxacin
dc.subject.otherErythromycin
dc.subject.otherFleroxacin
dc.subject.otherGatifloxacin
dc.subject.otherMacrolide
dc.subject.otherMitozolomide
dc.subject.otherNorfloxacin
dc.subject.otherOmeprazole
dc.subject.otherPenicillin G
dc.subject.otherProdrug
dc.subject.otherQuinoline derived antiinfective agent
dc.subject.otherRifampicin
dc.subject.otherTemozolomide
dc.subject.otherTriclosan
dc.subject.otherUnindexed drug
dc.subject.otherVancomycin
dc.subject.otherAntibacterial activity
dc.subject.otherAntibiotic resistance
dc.subject.otherBacterial infection
dc.subject.otherDrug design
dc.subject.otherDrug efficacy
dc.subject.otherHuman
dc.subject.otherMinimum inhibitory concentration
dc.subject.otherNonhuman
dc.subject.otherRespiratory tract infection
dc.subject.otherReview
dc.subject.otherSepticemia
dc.subject.otherSkin infection
dc.subject.otherUrinary tract infection
dc.subject.otherWound infection
dc.subject.otherAnti-Bacterial Agents
dc.subject.otherBacteria
dc.subject.otherModels, Molecular
dc.subject.otherProdrugs
dc.subject.otherStructure-Activity Relationship
dc.titleDual action-based approaches to antibacterial agents
dc.typeReview
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-34250160226&doi=10.2174%2f092986707780831168&partnerID=40&md5=4085a139fa0884a223c2597ccb7635d3

Files

Collections

Scopus: Year 1983-2021